Literature DB >> 26215293

Impact of Smoking and Excess Body Weight on Overall and Site-Specific Cancer Mortality Risk.

Julia Meyer1, Sabine Rohrmann1, Matthias Bopp1, David Faeh2.   

Abstract

BACKGROUND: Smoking and excess body weight are major preventable risk factors for premature death. This study aimed at analyzing their single and combined association with site-specific cancer mortality.
METHODS: Our study population comprised 35,784 men and women of ages 14 to 99 years, who participated in population-based health surveys conducted 1977-1993 in Switzerland and were followed up for mortality until 2008. Multivariable Cox proportional hazards models were calculated for different cancer sites, and population attributable fractions were derived.
RESULTS: The hazard ratio of dying from cancer (all sites) was 2.32 (95% confidence interval, 2.04-2.63) for heavy smokers (vs. never smokers) and 1.15 (1.01-1.32) for obese [body mass index (BMI) ≥ 30 kg/m(2)] vs. normal weight individuals. Heavy smoking (≥20 cigarettes/day) was associated with increased mortality due to cancer of the lung, upper aero-digestive tract, pancreas, bladder, liver, and the total of remaining sites. Obesity was associated with higher risk of dying from cancer of the liver and the female genital tract (essentially corpus or cervix uteri and ovary). More than 20% of all cancer deaths in our population were attributable to ever smoking and overweight (BMI ≥ 25 kg/m(2)).
CONCLUSIONS: Smoking was a much stronger risk factor for cancer than excess body weight. For lung, liver, and pancreatic cancer, the combination of excess body weight and smoking lead to cumulated higher risks. IMPACT: Our findings support recommendations for obese persons to quit smoking despite potential postcessation weight gain. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26215293     DOI: 10.1158/1055-9965.EPI-15-0415

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.

Authors:  J Wang; H Xu; S Zhou; D Wang; L Zhu; J Hou; J Tang; J Zhao; S Zhong
Journal:  Eur J Clin Nutr       Date:  2017-05-17       Impact factor: 4.016

2.  Relationship between anti-depressant use and lung cancer survival.

Authors:  Adriana Zingone; Derek Brown; Elise D Bowman; Oscar Vidal; Julien Sage; Joel Neal; Bríd M Ryan
Journal:  Cancer Treat Res Commun       Date:  2017-01-29

3.  Obesity is Independently Associated With Increased Risk of Hepatocellular Cancer-related Mortality: A Systematic Review and Meta-Analysis.

Authors:  Arjun Gupta; Avash Das; Kaustav Majumder; Nivedita Arora; Helen G Mayo; Preet P Singh; Muhammad S Beg; Siddharth Singh
Journal:  Am J Clin Oncol       Date:  2018-09       Impact factor: 2.339

Review 4.  Excess Body Weight and Gastrointestinal Cancer Risk.

Authors:  Hans Scherübl
Journal:  Visc Med       Date:  2021-04-13

Review 5.  Tobacco Smoking and Gastrointestinal Cancer Risk.

Authors:  Hans Scherübl
Journal:  Visc Med       Date:  2022-03-17

6.  Understanding the Relationship of Cigarette Smoking Trajectories Through Adolescence and Weight Status in Young Adulthood in the United States.

Authors:  Minal Patel; Annette Kaufman; Yvonne Hunt; Linda Nebeling
Journal:  J Adolesc Health       Date:  2017-04-18       Impact factor: 5.012

Review 7.  Tobacco and alcohol as risk factors for pancreatic cancer.

Authors:  Murray Korc; Christie Y Jeon; Mouad Edderkaoui; Stephen J Pandol; Maxim S Petrov
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-09-06       Impact factor: 3.043

8.  Associations between body mass index and the risk of mortality from lung cancer: A dose-response PRISMA-compliant meta-analysis of prospective cohort studies.

Authors:  Ning Shen; Ping Fu; Bin Cui; Chun-Ying Bu; Jing-Wang Bi
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

9.  Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study.

Authors:  Qiwen Ben; Jie Zhong; Jian Fei; Haitao Chen; Lifen Yv; Jihong Tan; Yaozong Yuan
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

10.  High prevalence of diabetes mellitus and impaired glucose tolerance in liver cancer patients: A hospital based study of 4610 patients with benign tumors or specific cancers.

Authors:  Chen Roujun; Yi Yanhua; Li Bixun
Journal:  F1000Res       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.